查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786465

全球藥物釋放型球囊導管市場

Drug-Eluting Balloon Catheters
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 279 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球藥物釋放型球囊導管市場規模將達到 9.359 億美元

全球藥物釋放型球囊導管市場規模預計在2024年達到6.188億美元，預計2024年至2030年期間的複合年成長率為7.1%，到2030年將達到9.359億美元。聚氨酯是本報告分析的細分市場之一，預計其複合年成長率為6.1%，到分析期結束時規模將達到5.327億美元。尼龍細分市場在分析期間的複合年成長率預計為8.1%。

美國市場規模估計為 1.686 億美元，中國市場預計複合年成長率為 11.0%

美國藥物釋放型球囊導管市場規模預計2024年達到1.686億美元。作為世界第二大經濟體，中國市場規模預計在2030年達到1.943億美元，2024年至2030年的複合年成長率為11.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為3.6%和6.8%。在歐洲，預計德國市場的複合年成長率為4.7%。

全球藥物釋放型球囊導管市場－主要趨勢與促進因素摘要

為什麼血管介入治療選用藥物釋放型球囊導管？

心血管疾病 (CVD) 和周邊動脈疾病(PAD) 的增多顯著增加了對藥物釋放型球囊 (DEB) 導管的需求，這是傳統支架的微創且高效的替代品。這些導管將抗增殖藥物（如紫杉醇或Sirolimus）直接輸送到受影響的動脈，減少血管再阻塞並最大程度地減少再次手術的需要。與留下永久植入的藥物釋放型支架 (DES) 不同，DEB 提供一種臨時但有效的治療方案，確保血管通暢性，而不會出現晚期血栓症等長期併發症。這使得 DEB 對高出血風險患者、患有小血管疾病的患者或接受反覆干預的患者特別有益。此外，人們對微創治療的偏好日益成長，尤其是在老年族群中，這推動了 DEB 導管在冠狀動脈、周邊和動靜脈瘺 (AVF) 手術中的廣泛應用。

哪些創新增強了藥物釋放型球囊導管的有效性？

無聚合物藥物塗層、藥物保留延長策略和靶向藥物傳輸機制的突破正在推動 DEB 技術的改進。下一代親水性載體、奈米藥物製劑和生物可吸收材料顯著增強了藥物在動脈壁上的黏附性，確保了持續的治療效果。球囊設計和導管靈活性的進步也提高了藥物輸送的精準度和安全性，最大限度地降低了手術風險並最佳化了治療效果。此外，血管內超音波(IVUS) 和光同調斷層掃瞄(OCT) 等即時成像技術正在整合到 DEB 系統中，從而提高了可視化和放置精度。隨著美國食品藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 等監管機構核准更多針對特定適應症的 DEB，市場上評估其在糖尿病血管併發症、膝下介入和透析通路維護方面的療效的臨床試驗數量激增。

監理要求和市場趨勢如何推動 DEB 的採用？

越來越多的監管核准DEB 用於多種血管疾病，這加速了其在全球的推廣。在歐洲，DEB 已被廣泛接受為支架內血管再阻塞的一線治療，而美國和亞太地區的監管機構正在擴大其適應症，涵蓋冠狀動脈、周邊血管甚至神經血管應用。由於導管介入手術成本效益高且住院時間短，醫院和門診手術中心正轉向導管介入手術，這進一步推動了需求。此外，政府推動價值導向型醫療保健和門診血管成形術的舉措也大力支持 DEB 的使用。日益重視將 DEB 與生物可吸收支架結合的混合手術也是一個關鍵的市場趨勢，這將改善長期血管癒合效果。

市場成長的主要驅動力是什麼？

藥物洗脫球囊導管市場的成長得益於心血管疾病和周邊動脈疾病負擔的增加、藥物輸送奈米技術的進步以及微創血管內治療的不斷普及。 DEB 應用範圍不斷擴展，不再局限於冠狀動脈介入治療，尤其是在糖尿病足潰瘍、危急性肢體缺血和血液透析機失敗的治療中，這創造了新的市場機會。此外，醫療支出的增加、介入性心臟病學投資的增加以及向門診血管成形術中心的轉變，都在支持市場擴張。隨著技術的不斷進步和臨床檢驗的不斷深入，DEB 導管正在成為下一代血管護理的重要組成部分。

部分

材料（聚氨酯、尼龍、其他）；最終用途（醫院和診所、門診手術中心、心導管室）

受訪公司範例

  • Balton Sp z oo
  • Becton, Dickinson and Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Eurocor GmbH
  • iVascular SLU
  • JIANGSU CHANGMEI MEDTECH CO., LTD

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，其中包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP30609

Global Drug-Eluting Balloon Catheters Market to Reach US$935.9 Million by 2030

The global market for Drug-Eluting Balloon Catheters estimated at US$618.8 Million in the year 2024, is expected to reach US$935.9 Million by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Polyurethane, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$532.7 Million by the end of the analysis period. Growth in the Nylon segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$168.6 Million While China is Forecast to Grow at 11.0% CAGR

The Drug-Eluting Balloon Catheters market in the U.S. is estimated at US$168.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$194.3 Million by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global "Drug-Eluting Balloon Catheters" Market - Key Trends & Drivers Summarized

Why Are Drug-Eluting Balloon Catheters a Preferred Choice for Vascular Interventions?

The rise in cardiovascular diseases (CVDs) and peripheral artery diseases (PADs) has significantly increased the demand for drug-eluting balloon (DEB) catheters, which offer a less invasive and highly effective alternative to traditional stents. These catheters deliver antiproliferative drugs, such as paclitaxel and sirolimus, directly to the affected arteries, reducing restenosis and minimizing the need for repeat procedures. Unlike drug-eluting stents (DES), which leave behind a permanent implant, DEBs provide a transient yet effective therapeutic solution, ensuring vessel patency without long-term complications like late thrombosis. This makes them particularly beneficial for patients with high risks of bleeding, small vessel disease, or those undergoing repeat interventions. Additionally, the growing preference for minimally invasive procedures, especially among aging populations, has driven the increased adoption of DEB catheters in coronary, peripheral, and arteriovenous fistula (AVF) treatments.

What Innovations Are Enhancing the Effectiveness of Drug-Eluting Balloon Catheters?

Breakthroughs in polymer-free drug coatings, prolonged drug retention strategies, and targeted drug delivery mechanisms are driving improvements in DEB technology. Next-generation hydrophilic carriers, nano-based drug formulations, and bioabsorbable materials have significantly enhanced drug adhesion to arterial walls, ensuring sustained therapeutic effects. Advancements in balloon design and catheter flexibility have also improved the precision and safety of drug delivery, minimizing procedural risks and optimizing outcomes. Furthermore, real-time imaging technologies, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are now being integrated into DEB systems, allowing for enhanced visualization and placement accuracy. As regulatory bodies such as the FDA and European Medicines Agency (EMA) approve more indication-specific DEBs, the market is witnessing a surge in clinical trials evaluating their efficacy in diabetic vascular complications, below-the-knee interventions, and dialysis access maintenance.

How Are Regulatory Mandates and Market Trends Driving Adoption?

The increasing regulatory approvals for DEBs across multiple vascular indications have accelerated their global adoption. In Europe, drug-eluting balloon catheters have already gained widespread acceptance as a first-line treatment for in-stent restenosis, while regulatory agencies in the U.S. and Asia-Pacific are expanding approvals for coronary, peripheral, and even neurovascular applications. Hospitals and ambulatory surgical centers are shifting towards catheter-based interventions due to their cost-effectiveness and shorter hospital stays, further fueling demand. Additionally, government initiatives promoting value-based healthcare and outpatient angioplasty procedures have provided a strong push toward DEB utilization. The growing emphasis on hybrid procedures that combine DEBs with bioresorbable scaffolds is also a key market trend, offering better long-term vascular healing outcomes.

What Are the Primary Market Growth Drivers?

The growth in the Drug-Eluting Balloon Catheter market is driven by the increasing burden of cardiovascular and peripheral artery diseases, advancements in drug delivery nanotechnology, and the rising adoption of minimally invasive endovascular procedures. The expansion of DEB applications beyond coronary interventions, particularly in treating diabetic foot ulcers, critical limb ischemia, and hemodialysis access failures, has created new market opportunities. Additionally, rising healthcare expenditures, increasing investments in interventional cardiology, and the shift toward outpatient angioplasty centers are supporting market expansion. With ongoing technological advancements and continuous clinical validation, DEB catheters are poised to become an indispensable component of next-generation vascular care.

SCOPE OF STUDY:

The report analyzes the Drug-Eluting Balloon Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Material (Polyurethane, Nylon, Others); End-Use (Hospitals & Clinics, Ambulatory Surgery Centers, Catheterization Laboratories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Balton Sp z o.o.
  • Becton, Dickinson and Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Eurocor GmbH
  • iVascular S.L.U
  • JIANGSU CHANGMEI MEDTECH CO., LTD

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Drug-Eluting Balloon Catheters - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Peripheral Artery Disease Spurs Demand for Drug-Eluting Balloon Catheters
    • Aging Population and Prevalence of Chronic Cardiovascular Conditions Strengthen Business Case for Drug-Eluting Therapies
    • Increasing Preference for Minimally Invasive Procedures Accelerates Adoption of Drug-Eluting Balloon Catheters
    • Clinical Success and Favorable Outcomes Propel Growth of Drug-Eluting Balloon Technologies
    • Shorter Recovery Times and Reduced Restenosis Risk Drive Demand in Outpatient and Day-Care Surgical Settings
    • Technological Innovations in Drug Coating and Delivery Systems Expand Addressable Market Opportunity
    • Surge in Endovascular Interventions Across Emerging Economies Throws the Spotlight on Drug-Eluting Balloons
    • Shift from Traditional Angioplasty to Drug-Eluting Devices Fuels Market Transformation
    • Integration of Biodegradable Materials in Balloon Catheters Drives Innovation-Led Growth
    • Favorable Reimbursement Policies in Developed Markets Sustain Growth Momentum
    • Expanding Pipeline of Clinical Trials and Regulatory Approvals Unlocks New Market Avenues
    • Expansion of Ambulatory Surgical Centers Across Urban and Semi-Urban Regions Generates New Demand Nodes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Drug-Eluting Balloon Catheters Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Polyurethane by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Nylon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Nylon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Nylon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Catheterization Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Catheterization Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Catheterization Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • JAPAN
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • CHINA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • EUROPE
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • FRANCE
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • GERMANY
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • INDIA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • AFRICA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030

IV. COMPETITION